Related Experiment Video

Updated: May 11, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Molecular targeted therapies for rhabdomyosarcoma: focus on hedgehog and apoptosis signaling

S Fulda1

  • 1Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Frankfurt a. Main, Germany.

Klinische Padiatrie
|April 30, 2013
PubMed

Insights

Understanding cell death and proliferation is key to rhabdomyosarcoma (RMS) treatment. Targeting pathways like hedgehog (Hh) offers new therapeutic strategies for this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Cell death and proliferation pathway dysfunction drives rhabdomyosarcoma (RMS) development, progression, and treatment resistance.
  • Identifying key molecular regulators of cancer cell survival is crucial for novel drug discovery.
  • Aberrant activation of the hedgehog (Hh) signaling pathway is frequently observed in RMS.

Purpose of the Study:

  • To explore the role of cell death and proliferation pathways in rhabdomyosarcoma.
  • To identify critical signaling molecules and hubs that control cancer cell fate.
  • To evaluate the therapeutic potential of targeting specific pathways in RMS.

Main Methods:

  • Investigating programmed cell death induction in RMS cells using various agents (proteins, antibodies, inhibitors).
  • Analyzing the aberrant activation of the hedgehog (Hh) cascade in RMS.
  • Reviewing current and emerging molecular targeted therapies for RMS.

Main Results:

  • Programmed cell death can be therapeutically engaged in RMS cells.
  • The hedgehog (Hh) pathway is a viable target for RMS intervention.
  • Molecularly targeted therapies show promise for improved RMS treatment outcomes.

Conclusions:

  • Targeting cell death and proliferation pathways presents a promising avenue for rhabdomyosarcoma treatment.
  • The hedgehog (Hh) cascade represents a significant therapeutic target in RMS.
  • Development of molecularly targeted drugs is essential for advancing RMS patient care.

More Related Videos

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...